Metabolomics in rheumatoid arthritis with versus without disease-modifying antirheumatic drug initiation
Year: 2024
Type: conference-paper
Abstract: Introduction: Rheumatoid arthritis (RA) significantly increases the overall risk of cardiovascular disease (CVD). In addition to conventional risk factors, the inflammatory activity of the disease itself and medications that promote atherosclerosis contribute to an even greater risk. However, there [for full text, please go to the a.m. URL]
DOI: 10.3205/24dgrh159
Authors: Patschan, Susann, Claus, Inga, Hoffmeister, Meike, Strathmeyer, Selina, Heelemann, Steffen, Remus, Constantin, Dammermann, Werner, Ritter, Oliver, Patschan, Daniel
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6908769178
FWCI:
Cites:
Cited by:
Related to:
